Get the Stockscreener App
12.40
4.11%
0.49
After Hours:
12.59
0.19
+1.53%
Schrodinger Inc stock is traded at $12.40, with a volume of 1.75M.
It is up +4.11% in the last 24 hours and down -0.88% over the past month.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
See More
Previous Close:
$11.91
Open:
$12.05
24h Volume:
1.75M
Relative Volume:
1.28
Market Cap:
$915.43M
Revenue:
$255.87M
Net Income/Loss:
$-103.27M
P/E Ratio:
-8.7887
EPS:
-1.4109
Net Cash Flow:
$12.46M
1W Performance:
+7.83%
1M Performance:
-0.88%
6M Performance:
-39.84%
1Y Performance:
-51.55%
1-Day Range:
$12.02
$12.64
1-Week Range:
$11.20
$12.64
52-Week Range:
$10.95
$27.63
Schrodinger Inc Stock (SDGR) Company Profile
Name
Schrodinger Inc
Sector
Industry
Phone
503-299-1150
Address
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
12.40 | 879.26M | 255.87M | -103.27M | 12.46M | -1.4109 |
VEEV
Veeva Systems Inc
|
167.30 | 25.98B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
56.41 | 8.89B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
46.01 | 8.89B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
83.67 | 6.87B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.68 | 4.30B | 1.10B | 112.09M | 283.19M | 0.6096 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-30-25 | Initiated | Goldman | Neutral |
| Aug-15-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-14-25 | Initiated | Barclays | Overweight |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-02-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-05-23 | Resumed | Piper Sandler | Overweight |
| Dec-19-22 | Initiated | Goldman | Neutral |
| Mar-01-22 | Initiated | Citigroup | Buy |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Nov-11-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-13-21 | Initiated | Berenberg | Buy |
| Sep-01-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-25-21 | Initiated | Craig Hallum | Buy |
| Nov-23-20 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-12-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-02-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-02-20 | Initiated | Jefferies | Hold |
| Mar-02-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Schrodinger Inc Stock (SDGR) Latest News
KeyBanc Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $20 - Moomoo
Understanding Momentum Shifts in (SDGR) - Stock Traders Daily
If You Invested $1,000 in Schrodinger, Inc. (SDGR) - Stock Titan
Schrodinger (HAM:43Z) Cash Receipts from Deposits by Banks and Customers - GuruFocus
Schrodinger (HAM:43Z) Other Assets for Banks - GuruFocus
Schrodinger Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Schrodinger Inc Stock Historical Valuations | HAM:43Z - GuruFocus
Schrodinger Inc Stock Intrinsic Values - GuruFocus
Schrodinger Inc (HAM:43Z) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Schrodinger Inc (HAM:43Z)Valuation Measures & Financial Statistics - GuruFocus
Schrodinger Inc (HAM:43Z) Stock News, Headlines & Updates - GuruFocus
Schrodinger Inc (HAM:43Z) Valuation: Possible Value Trap, Think Twice - GuruFocus
Schrodinger Inc Stock Warning Signs | HAM:43Z - GuruFocus
Who's Buying or Selling Schrodinger Inc (HAM:43Z) Stock Today? - GuruFocus
Schrodinger Inc (HAM:43Z) Competitors 2026 - GuruFocus
Schrodinger Inc (HAM:43Z) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Schrodinger Inc (HAM:43Z) Stock Earnings Transcripts - GuruFocus
Schrodinger Inc Stock Operating Data - GuruFocus
Schrodinger Inc (HAM:43Z) Dividend - GuruFocus
Schrodinger Inc (HAM:43Z) Stock Price & 30 Year Financial Data - GuruFocus
Schrodinger Inc (HAM:43Z) DCF Valuation - GuruFocus
SDGR Stock Chart | SCHRODINGER INC (NASDAQ:SDGR) - ChartMill
SDGR Technical Analysis & Stock Price Forecast - Intellectia AI
Schrödinger, Inc. (43Z.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
Schrodinger, Inc. (SDGR) Stock Forecasts - Yahoo Finance
SchröDinger: Transition Pressure And Competition Offset Ecosystem Strength (NASDAQ:SDGR) - Seeking Alpha
Avoiding Lag: Real-Time Signals in (SDGR) Movement - Stock Traders Daily
Schrodinger Inc Stock: Physics-Based Computing Leader in Drug Discovery and Materials Science for In - AD HOC NEWS
Schrodinger, Inc. (NASDAQ:SDGR) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Schrodinger (NASDAQ:SDGR) Sets New 52-Week LowTime to Sell? - MarketBeat
Vanguard disaggregates holdings; SDGR filing shows 0 shares (SDGR) - Stock Titan
Schrödinger Discontinues Clinical Program After Two Patient Deaths - MSN
Tudor Investment Corp ET AL Has $6.75 Million Position in Schrodinger, Inc. $SDGR - marketbeat.com
Transcript : Schrödinger, Inc. Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum, Mar-17-2026 09 - marketscreener.com
Schrodinger Conference: SDGR Targets Hosted Shift, Platform Adoption, EBITDA Profitability in 3 Years - Yahoo Finance
Discipline and Rules-Based Execution in SDGR Response - Stock Traders Daily
Schrödinger (SDGR) Morgan Stanley 22nd Annual Global Healthcare Conference Summary - Quartr
Schrodinger (SDGR) VP details stock, RSU and option holdings - Stock Titan
Schrodinger downgraded at Citi after clinical program exit - MSN
Schrödinger updates 2025 software growth guidance to 8%-13% amid pharma scale-up delays and operational efficiency focus - msn.com
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)March 18, 2026 - BioSpace
Schrodinger reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
SDGR: Analyst Michael Yee of UBS Lowers Price Target to $13, Mai - GuruFocus
UBS Group Cuts Schrodinger (NASDAQ:SDGR) Price Target to $13.00 - MarketBeat
Schrödinger at KeyBanc Forum: Strategic Shift to Hosted Contracts By Investing.com - Investing.com India
Schrödinger at KeyBanc Forum: Strategic Shift to Hosted Contracts - Investing.com
SDGR: Strategic shift to hosted software, AI integration, and new products drive growth and industry impact - TradingView
Schrodinger (SDGR) Upgraded to Buy by B of A Securities | SDGR S - GuruFocus
Farallon Capital Management LLC Lowers Holdings in Schrodinger, Inc. $SDGR - MarketBeat
Keybanc Maintains Schrödinger (SDGR) Overweight Recommendation - MSN
Schrödinger slides after early-stage trial data for cancer therapy - MSN
Schrodinger Inc Stock (SDGR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Schrodinger Inc Stock (SDGR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Herman Jenny | CAO |
Mar 06 '26 |
Sale |
12.84 |
608 |
7,808 |
34,804 |
| Jain Rachit | EVP & CFO |
Mar 05 '26 |
Sale |
12.90 |
1,631 |
21,033 |
52,596 |
| Tran Yvonne | EVP, CLO & CPO |
Mar 05 '26 |
Sale |
12.89 |
1,094 |
14,107 |
52,683 |
| Farid Ramy | President & CEO |
Mar 05 '26 |
Sale |
12.91 |
3,661 |
47,249 |
330,824 |
| Akinsanya Karen | See Remarks |
Mar 05 '26 |
Sale |
12.90 |
1,366 |
17,625 |
69,956 |
| Lorton Kenneth Patrick | EVP, CTO & COO, Software |
Mar 05 '26 |
Sale |
12.90 |
1,222 |
15,761 |
89,241 |
| Abel Robert Lorne | See Remarks |
Mar 04 '26 |
Sale |
12.81 |
1,300 |
16,653 |
55,897 |
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):